LYNBROOK, N.Y., May 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. /quotes/zigman/69079/delayed/quotes/nls/bstc BSTC +0.48% , a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results for the first quarter ended March 31, 2014 and provided a corporate update.
Help employers find you! Check out all the jobs and post your resume.
